$DRIO
DarioHealth Corp. Stock $drio

$drio Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000114420413060267 Filed on November 12, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue		$0.00
YoY Change
Gross Profit		$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.910M	$2.160M	$630.0K
YoY Change	189.39%	242.86%
% of Gross Profit
Research & Development	$1.740M	$1.078M	$391.3K
YoY Change		175.51%
% of Gross Profit
Depreciation & Amortization	$260.0K	$270.0K	$10.00K
YoY Change	2500.0%	2600.0%
% of Gross Profit
Operating Expenses	$3.650M	$3.238M	$391.3K
YoY Change	129.56%	727.56%
Operating Profit		-$3.238M	-$1.023M
YoY Change		216.45%
Interest Expense	$3.710M	-$230.0K	-$2.030M
YoY Change	1136.67%	-88.67%
% of Operating Profit
Other Income/Expense, Net		-$233.0K	-$2.033M
YoY Change		-88.54%
Pretax Income	$50.00K	-$3.470M	-$3.060M
YoY Change	-104.2%	13.4%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$50.00K	-$3.471M	-$3.056M
YoY Change	-104.2%	13.57%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.85
Diluted Earnings Per Share	$5.000M	-$0.85	-$306.0M
COMMON SHARES
Basic Shares Outstanding	20.07M shares	3.994M shares
Diluted Shares Outstanding		3.994M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.400M	$4.600M	$900.0K
YoY Change	84.62%	411.11%
Cash & Equivalents	$2.263M	$4.468M	$820.0K
Short-Term Investments	$200.0K	$100.0K	$0.00
Other Short-Term Assets	$52.00K	$0.00	$100.0K
YoY Change	-27.2%	-100.0%
Inventory	$0.00
Prepaid Expenses
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$2.930M	$5.163M	$2.000M
YoY Change	75.81%	158.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.145M	$1.372M	$100.0K
YoY Change	85.47%	1272.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$100.0K	$0.00
YoY Change
Total Long-Term Assets	$1.186M	$1.494M	$100.0K
YoY Change	82.77%	1393.66%
TOTAL ASSETS
Total Short-Term Assets	$2.930M	$5.163M	$2.000M
Total Long-Term Assets	$1.186M	$1.494M	$100.0K
Total Assets	$4.116M	$6.656M	$2.100M
YoY Change	77.76%	216.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$600.0K	$200.0K
YoY Change	100.0%	200.0%
Accrued Expenses	$591.0K		$400.0K
YoY Change	154.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.506M	$1.089M	$600.0K
YoY Change	165.72%	81.43%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.700M	$6.400M	$3.200M
YoY Change	-3.57%	100.0%
Total Long-Term Liabilities	$2.700M	$6.400M	$3.200M
YoY Change	-3.57%	100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.506M	$1.089M	$600.0K
Total Long-Term Liabilities	$2.700M	$6.400M	$3.200M
Total Liabilities	$4.200M	$7.500M	$3.800M
YoY Change	23.53%	97.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.00M
YoY Change
Common Stock	$0.00	$1.999K
YoY Change	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$86.00K	-$839.0K	-$1.700M
YoY Change
Total Liabilities & Shareholders Equity	$4.116M	$6.656M	$2.100M
YoY Change	77.76%	216.97%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	$50.00K	-$3.471M	-$3.056M
YoY Change	-104.2%	13.57%
Depreciation, Depletion And Amortization	$260.0K	$270.0K	$10.00K
YoY Change	2500.0%	2600.0%
Cash From Operating Activities	-$2.130M	-$2.450M	-$720.0K
YoY Change	45.89%	240.28%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$160.0K	-$10.00K
YoY Change	-82.0%	1500.0%
Acquisitions
YoY Change
Other Investing Activities	-$60.00K	$0.00	-$20.00K
YoY Change	500.0%	-100.0%
Cash From Investing Activities	-$160.0K	-$150.0K	-$30.00K
YoY Change	-68.63%	400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.00K	50.00K	560.0K
YoY Change	-97.07%	-91.07%
NET CHANGE
Cash From Operating Activities	-2.130M	-2.450M	-720.0K
Cash From Investing Activities	-160.0K	-150.0K	-30.00K
Cash From Financing Activities	70.00K	50.00K	560.0K
Net Change In Cash	-2.220M	-2.550M	-190.0K
YoY Change	-628.57%	1242.11%
FREE CASH FLOW
Cash From Operating Activities	-$2.130M	-$2.450M	-$720.0K
Capital Expenditures	-$90.00K	-$160.0K	-$10.00K
Free Cash Flow	-$2.040M	-$2.290M	-$710.0K
YoY Change	112.5%	222.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	566755	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	391269	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4467829	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3169110	USD
CY2012Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	128171	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41491	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4817296	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9910814	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1244053	USD
CY2013Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	14239	USD
CY2013Q3	us-gaap	Short Term Investments ShortTermInvestments	93861	USD
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	21566	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	586686	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	5162615	USD
CY2013Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	121538	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	31545	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1372126	USD
CY2013Q3	us-gaap	Assets Assets	6656279	USD
CY2013Q3	drio	Other Accounts Payable And Accrued Expenses OtherAccountsPayableAndAccruedExpenses	533735	USD
CY2012Q4	drio	Other Accounts Payable And Accrued Expenses OtherAccountsPayableAndAccruedExpenses	316403	USD
CY2013Q3	drio	Liability Related To Warrants LiabilityRelatedToWarrants	6406680	USD
CY2012Q4	drio	Liability Related To Warrants LiabilityRelatedToWarrants	2817741	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	1999	USD
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19216234	USD
CY2013Q3	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	20057225	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-838992	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6656279	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1077891	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1012087	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4748270	USD
CY2013Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	763317	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2220395	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	503776	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3238573	USD
CY2013Q3	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-191898	USD
CY2012Q3	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-2033217	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-3991875	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-2006777	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-5582386	USD
CY2013Q3	drio	Issuancecostofwarrents Issuancecostofwarrents	0	USD
CY2012Q3	drio	Issuancecostofwarrents Issuancecostofwarrents	0	USD
	drio	Issuancecostofwarrents Issuancecostofwarrents	0	USD
	drio	Issuancecostofwarrents Issuancecostofwarrents	-101263	USD
	drio	Issuancecostofwarrents Issuancecostofwarrents	-257360	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4074489	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-3471962	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20057225	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17757793	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11676809	shares
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1023216	USD
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	250352	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1230034	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7151270	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1088591	USD
CY2013Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	554856	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2384311	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	128171	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1924408	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1397365	USD
	us-gaap	Net Income Loss NetIncomeLoss	-385349	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	278	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82614	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1917	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-97544	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-233389	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2032939	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	13422	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	401522	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1666544	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	617364	USD
CY2012Q4	us-gaap	Assets Assets	2315453	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1454	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5001425	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	6071922	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-1069043	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2315453	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-5686573	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14119935	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2109957	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5937290	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-3056155	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13985303	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4494268	USD
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	0	USD
	drio	Stock Issued During Period Value Issued For Services2 StockIssuedDuringPeriodValueIssuedForServices2	650	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.79
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19972409	shares
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12167528	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	USD
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
	drio	Legal And Professional Fees LegalAndProfessionalFees	282109	USD
	drio	Legal And Professional Fees LegalAndProfessionalFees	1246183	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-88748	USD
	drio	Stock Issued During Period Value Issued For Services1 StockIssuedDuringPeriodValueIssuedForServices1	100	USD
	drio	Stock Issued During Period Value New Issues October And November2011 StockIssuedDuringPeriodValueNewIssuesOctoberAndNovember2011	481490	USD
	drio	Stock Issued During Period Value New Issues December2011 StockIssuedDuringPeriodValueNewIssuesDecember2011	86253	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	193144	USD
CY2012	drio	Stock Issued During Period Value New Issues February And March2012 StockIssuedDuringPeriodValueNewIssuesFebruaryAndMarch2012	540109	USD
CY2012	drio	Stock And Warrant Issued During Period Value New Issues August2012 StockAndWarrantIssuedDuringPeriodValueNewIssuesAugust2012	498157	USD
CY2012	drio	Stock Issued During Period Value New Issues September And October2012 StockIssuedDuringPeriodValueNewIssuesSeptemberAndOctober2012	2384478	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	437499	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	564143	USD
	drio	Stock And Warrant Issued During Period Value New Issues February2013 StockAndWarrantIssuedDuringPeriodValueNewIssuesFebruary2013	498011	USD
	drio	Stockissuedduringperiodvaluewarrantsnetofissuesaprilandmay2013 Stockissuedduringperiodvaluewarrantsnetofissuesaprilandmay2013	8985510	USD
	drio	Stockissuedduringperiodvaluewarrantsissuesjune2013 Stockissuedduringperiodvaluewarrantsissuesjune2013	498411	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	487870	USD
	drio	Warrant Issued During Period For Services Value WarrantIssuedDuringPeriodForServicesValue	523500	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15	USD
	drio	Stockissuedduringperiodvaluewarrantsexercised Stockissuedduringperiodvaluewarrantsexercised	628551	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2593486	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	3604856	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	481048	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	4606449	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	101263	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	258110	USD
	us-gaap	Depreciation Depreciation	577653	USD
	us-gaap	Depreciation Depreciation	6748	USD
	us-gaap	Depreciation Depreciation	602474	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	155942	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	77280	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	560019	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	275600	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	187691	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	525952	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	217332	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	268766	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	533735	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-3991875	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-2006777	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-5582386	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5473929	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1519255	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8508138	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	105028	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19851	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	138316	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	35408	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	48170	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	105589	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	0	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	135591	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1308273	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33645	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1950458	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	13422	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1483482	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53496	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2189617	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	9969591	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	1484003	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	14939969	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10195206	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1484003	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15165584	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3237795	USD
	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	78509	USD
	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	25216	USD
	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	193911	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4467829	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	908765	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	820017	USD
	drio	Noncash Or Part Noncash Acquisition Receivable On Account Of Shares NoncashOrPartNoncashAcquisitionReceivableOnAccountOfShares	12341	USD
	drio	Noncash Or Part Noncash Acquisition Receivable On Account Of Shares NoncashOrPartNoncashAcquisitionReceivableOnAccountOfShares	1050074	USD
	drio	Noncash Or Part Noncash Acquisition Receivable On Account Of Shares NoncashOrPartNoncashAcquisitionReceivableOnAccountOfShares	12341	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	28904	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	28904	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	402936	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	0	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	402936	USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19998654	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14547689	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19998654	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14547689	shares
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	742616	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2593486	USD
CY2013Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	374130	USD
CY2012Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	271562	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	908384	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	595462	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1944641	USD
CY2013Q3	drio	Legal And Professional Fees LegalAndProfessionalFees	423135	USD
CY2012Q3	drio	Legal And Professional Fees LegalAndProfessionalFees	180686	USD
	drio	Legal And Professional Fees LegalAndProfessionalFees	891761	USD
CY2013Q3	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
CY2012Q3	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	1011370	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	1448861	USD
CY2013Q3	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	31369	USD
CY2012Q3	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	3066	USD
CY2013Q1	drio	Number Of Warrants Issued During Period NumberOfWarrantsIssuedDuringPeriod	250000	shares
CY2013Q1	drio	Exercise Price Of Warrants ExercisePriceOfWarrants	1.50
CY2013Q1	drio	Number Of Warrants Issued During Period One NumberOfWarrantsIssuedDuringPeriodOne	200000	shares
CY2013Q1	drio	Stock To Be Issued Upon Coversion Of Warrants One StockToBeIssuedUponCoversionOfWarrantsOne	200000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	390000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2013-03-31
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	664363	USD
CY2012	drio	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Investors And Service Provider FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInvestorsAndServiceProvider	547000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	1606378	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2817741	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3991875	USD
	drio	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercised Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExercisedWarrants	-402936	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6406680	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Trading Symbol TradingSymbol	DRIO
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20067937	shares
	dei	Entity Registrant Name EntityRegistrantName	LabStyle Innovations Corp.
	dei	Entity Central Index Key EntityCentralIndexKey	0001533998
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q1	drio	Share Based Compensation Arrangement By Share Based Payment Award Options To Nonemployee Director Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToNonemployeeDirectorGrantsInPeriod	600000	shares
CY2013Q1	drio	Share Based Compensation Arrangements By Share Based Payment Award Options Grants To Nonemployee Director In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsToNonemployeeDirectorInPeriodWeightedAverageExercisePrice	1.50
CY2013Q1	drio	Share Based Compensation Arrangement By Share Based Payment Award To Nonemployee Expiration Period ShareBasedCompensationArrangementByShareBasedPaymentAwardToNonemployeeExpirationPeriod	P10Y
CY2013Q1	drio	Unvested Shares Of Common Stock UnvestedSharesOfCommonStock	166668	shares
CY2013Q1	drio	Unvested Shares Of Common Stock At Four Monthly Issuances UnvestedSharesOfCommonStockAtFourMonthlyIssuances	41667	shares
CY2013Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2038262	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	225615	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	0	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	225615	USD
CY2013Q1	drio	Stock Registered During Period Shares Initial Registration StockRegisteredDuringPeriodSharesInitialRegistration	9430162	shares
CY2013Q3	drio	Stock Registered During Period Shares Second Registration StockRegisteredDuringPeriodSharesSecondRegistration	7936690	shares
CY2013Q3	drio	General And Administrative Expenses Related To Warrants GeneralAndAdministrativeExpensesRelatedToWarrants	237500	USD
	drio	General And Administrative Expenses Related To Warrants GeneralAndAdministrativeExpensesRelatedToWarrants	286000	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	568731	USD
CY2012Q3	us-gaap	Share Based Compensation ShareBasedCompensation	48462	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1927272	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	341266	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2317674	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	225615	USD

Files In Submission

Name	View Source	Status
0001144204-13-060267-index-headers.html	Edgar Link	pending
0001144204-13-060267-index.html	Edgar Link	pending
0001144204-13-060267.txt	Edgar Link	pending
0001144204-13-060267-xbrl.zip	Edgar Link	pending
drio-20130930.xml	Edgar Link	completed
drio-20130930.xsd	Edgar Link	pending
drio-20130930_cal.xml	Edgar Link	unprocessable
drio-20130930_def.xml	Edgar Link	unprocessable
drio-20130930_lab.xml	Edgar Link	unprocessable
drio-20130930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v358648_10q.htm	Edgar Link	pending
v358648_ex31-1.htm	Edgar Link	pending
v358648_ex31-2.htm	Edgar Link	pending
v358648_ex32-1.htm	Edgar Link	pending
v358648_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DRIO
DarioHealth Corp. Stock $drio

2013 Q4 Form 10-Q Financial Statement

#000114420413060267 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO DarioHealth Corp. Stock $drio

2013 Q4 Form 10-Q Financial Statement

#000114420413060267 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO
DarioHealth Corp. Stock $drio